Exact Sciences (EXAS) Stock Forecast
AI forecast: EXAS
There is no current AI forecast for this stock.
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock PremiumAbout This Company
Exact Sciences Corp. develops and commercializes non-invasive molecular screening tests for the early detection and prevention of colorectal cancer. The DNA-based test helps identify precancerous conditions and the presence of cancer by detecting genetic mutations in colon cells.